Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03404596Phase 1Completed
Phase 1, open-label, single-arm trial in Tobacco Use Disorder (TUD), sponsored by Moffitt Cancer Center. Primary endpoints: Rate of Smoking Lapse at 36 months and Rate of Stress at 36 months. Started Jul 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03404596.